生物标志物 生物标志物
Jacob Apibilla Ayembilla1, Yannick Joel Wadop Ngouongo2, Biniyam A Ayele3,4,5
1Accra Technical University, Accra, Greater Accra Region, Ghana.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
大脑脊髓液 (CSF) 中脂肪酸的变化可以帮助在老年人中诊断轻度认知障碍 (MCI),可能是在粉样蛋白和蛋白异常出现之前. 这些发现可能会导致预防认知衰退的新策略.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 生物标志物发现发现
背景情况:
- 脂肪酸对神经元膜结构至关重要,但它们在认知和新陈代谢中的作用尚未完全理解.
- 轻度认知障碍 (MCI) 影响认知,是痴呆症的危险因素.
- 脑脊液 (CSF) 分析提供了对大脑健康和疾病过程的见解.
研究的目的:
- 评估CSF中脂肪酸的诊断性能,以区分MCI和认知正常 (CU) 个体.
- 为了比较CSF脂肪酸的诊断实用性与已知的生物标志物,如Aβ42和tau.
- 研究CSF脂肪酸和传统生物标志物的联合诊断能力.
主要方法:
- 对和脂肪酸 (SAFA),单不和脂肪酸 (MUFA) 和多不和脂肪酸 (PUFA) 在三种CSF分数 (未化,超,纳米颗粒) 的分析.
- 利用了HMRI衰老研究中68个CU和38个MCI参与者的数据.
- 采用多变量二元物流回归和ROC曲线分析,调整年龄,性别和病史等共变量.
主要成果:
- 特定的脂肪酸比例和水平 (例如,棕酸/棕酸) 在MCI检测方面显示出显著的诊断性能 (AUC 0.66-0.71).
- 在区分MCI和CU时,CSF脂肪酸的表现优于Aβ42,tau和它们的比率 (AUC0.53-0.55).
- 将CSF脂肪酸与Aβ42/tau比率的整合提高了诊断的准确性.
结论:
- 脂肪酸代谢的改变可能是MCI的早期指标,先于粉样蛋白和蛋白病理.
- 脑流脂肪酸分析作为早期认知衰退的新型诊断工具具有前景.
- 向脂肪酸代谢可以提供一种治疗策略,以减轻老年人群的认知衰退.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516